PROTEIN MODIFICATION AND MAINTENANCE MOLECULES

Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KHARE, REENA, HAFALIA, APRIL, J., A, LI, JOANA, X, SPRAGUE, WILLIAM, W, RAMKUMAR, JAYALAXMI, CHANG, HSIN-RU, GORVAD, ANN, E, CHAWLA, NARINDER, K, LEE, SOO, YEUN, ELLIOTT, VICKI, S
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating , or preventing disorders associated with aberrant expression of PMMM. Various embodiments of the invention provide human protein modification and maintenance molecules PMMM and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating , or preventing disorders associated with aberrant expression of PMMM. Plusieurs formes de réalisation de la présente invention se rapportent à des molécules de modification et d'entretien de protéines humaines (MMEP) et à des polynucléotides qui identifient et codent MMEP. Des formes de réalisation de la présente invention concernent également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. D'autres formes de réalisation concernent des méthodes de diagnostic, de traitement ou de prévention de troubles associés à l'expression aberrante de MMEP.